Revolutionary Aurora Defibrillator Implanted for the First Time at UMG

A new type of defibrillator has been implanted for the first time at the University Medical Center Göttingen (UMG). The Aurora system, a next-generation device, aims to reduce risks linked to traditional implants. Each year, sudden cardiac death claims 65,000 lives in Germany alone—many caused by dangerous heart rhythms. Sudden cardiac death often occurs when the heart's lower chambers beat erratically, a condition called ventricular fibrillation. For high-risk patients, such as those with severe heart failure, an implantable cardioverter-defibrillator (ICD) can be life-saving. However, conventional ICDs carry risks, including electrode fractures or lung damage during surgery.

The Aurora system addresses these issues with a new design. Its electrode sits beneath the sternum, directly on the heart's surface, while the defibrillator unit is placed under the left armpit. This approach lowers the chance of infections spreading into the bloodstream—a particular advantage for dialysis patients. UMG's Heart Center, which combines 14 clinics and institutes, recently performed the first implantation of the Aurora system in a patient with arrhythmias. The centre focuses on integrated care for heart, vascular, lung, and kidney conditions, emphasising quality and transparency. The Aurora system has already received approval for use across Europe.

The first successful implantation of the Aurora system at UMG marks a step forward in treating high-risk heart patients. The device's design reduces common complications, offering a safer alternative to older models. Sudden cardiac death remains a major health concern, but innovations like this aim to improve survival rates.